Cart
sales@molnova.com
Irinotecan Hydrochloride
CAS No. 100286-90-6
Irinotecan Hydrochloride( —— )
Catalog No. M10029 CAS No. 100286-90-6
Irinotecan Hcl(CPT-11 Hcl) prevents DNA from unwinding by inhibition of topoisomerase 1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 65 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 42 | In Stock |
|
| 50MG | 59 | In Stock |
|
| 100MG | 89 | In Stock |
|
| 200MG | 128 | In Stock |
|
| 500MG | 262 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIrinotecan Hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionIrinotecan Hcl(CPT-11 Hcl) prevents DNA from unwinding by inhibition of topoisomerase 1.
-
DescriptionIrinotecan Hcl(CPT-11 Hcl) prevents DNA from unwinding by inhibition of topoisomerase 1.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetTopoisomerase
-
RecptorTopo I
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number100286-90-6
-
Formula Weight623.14
-
Molecular FormulaC33H39ClN4O6
-
Purity>98% (HPLC)
-
SolubilitySoluble in Water
-
SMILESCCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yoshikawa M, et al. Int J Y. 2004 Jul 20;110(6):921-7.
molnova catalog
related products
-
GW842166X
GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 of 63 nM, shows no significant activity at CB1 receptor. Phase 2.
-
Heveaflavone
Heveaflavone has anti-proliferation effects, it shows moderate Topoisomerase I inhibitory activity. It also possesses a good antioxidant activity via its DPPH free radical scavenging.
-
DRF-1042
DRF-1042, an orally active camptothecin analog, exhibits anticancer and insecticidal activities by inhibiting DNA topoisomerase I. It has been studied for its efficacy against solid tumors, including prostate and colon cancers.
